358 related articles for article (PubMed ID: 24866401)
1. Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers.
van Blitterswijk M; Mullen B; Heckman MG; Baker MC; DeJesus-Hernandez M; Brown PH; Murray ME; Hsiung GY; Stewart H; Karydas AM; Finger E; Kertesz A; Bigio EH; Weintraub S; Mesulam M; Hatanpaa KJ; White CL; Neumann M; Strong MJ; Beach TG; Wszolek ZK; Lippa C; Caselli R; Petrucelli L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Mackenzie IR; Seeley WW; Grinberg LT; Miller BL; Boylan KB; Graff-Radford NR; Boeve BF; Dickson DW; Rademakers R
Neurobiol Aging; 2014 Oct; 35(10):2421.e13-7. PubMed ID: 24866401
[TBL] [Abstract][Full Text] [Related]
2. Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders.
Lattante S; Millecamps S; Stevanin G; Rivaud-Péchoux S; Moigneu C; Camuzat A; Da Barroca S; Mundwiller E; Couarch P; Salachas F; Hannequin D; Meininger V; Pasquier F; Seilhean D; Couratier P; Danel-Brunaud V; Bonnet AM; Tranchant C; LeGuern E; Brice A; Le Ber I; Kabashi E;
Neurology; 2014 Sep; 83(11):990-5. PubMed ID: 25098532
[TBL] [Abstract][Full Text] [Related]
3. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia.
van Blitterswijk M; Mullen B; Nicholson AM; Bieniek KF; Heckman MG; Baker MC; DeJesus-Hernandez M; Finch NA; Brown PH; Murray ME; Hsiung GY; Stewart H; Karydas AM; Finger E; Kertesz A; Bigio EH; Weintraub S; Mesulam M; Hatanpaa KJ; White CL; Strong MJ; Beach TG; Wszolek ZK; Lippa C; Caselli R; Petrucelli L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Mackenzie IR; Seeley WW; Grinberg LT; Miller BL; Boylan KB; Graff-Radford NR; Boeve BF; Dickson DW; Rademakers R
Acta Neuropathol; 2014 Mar; 127(3):397-406. PubMed ID: 24385136
[TBL] [Abstract][Full Text] [Related]
4. Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort study.
van Blitterswijk M; DeJesus-Hernandez M; Niemantsverdriet E; Murray ME; Heckman MG; Diehl NN; Brown PH; Baker MC; Finch NA; Bauer PO; Serrano G; Beach TG; Josephs KA; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Boylan KB; Petrucelli L; Dickson DW; Rademakers R
Lancet Neurol; 2013 Oct; 12(10):978-88. PubMed ID: 24011653
[TBL] [Abstract][Full Text] [Related]
5. Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene.
van Blitterswijk M; Mullen B; Wojtas A; Heckman MG; Diehl NN; Baker MC; DeJesus-Hernandez M; Brown PH; Murray ME; Hsiung GY; Stewart H; Karydas AM; Finger E; Kertesz A; Bigio EH; Weintraub S; Mesulam M; Hatanpaa KJ; White CL; Neumann M; Strong MJ; Beach TG; Wszolek ZK; Lippa C; Caselli R; Petrucelli L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Mackenzie IR; Seeley WW; Grinberg LT; Miller BL; Boylan KB; Graff-Radford NR; Boeve BF; Dickson DW; Rademakers R
Mol Neurodegener; 2014 Sep; 9():38. PubMed ID: 25239657
[TBL] [Abstract][Full Text] [Related]
6. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.
Gendron TF; van Blitterswijk M; Bieniek KF; Daughrity LM; Jiang J; Rush BK; Pedraza O; Lucas JA; Murray ME; Desaro P; Robertson A; Overstreet K; Thomas CS; Crook JE; Castanedes-Casey M; Rousseau L; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; Rademakers R; Lagier-Tourenne C; Edbauer D; Cleveland DW; Dickson DW; Petrucelli L; Boylan KB
Acta Neuropathol; 2015 Oct; 130(4):559-73. PubMed ID: 26350237
[TBL] [Abstract][Full Text] [Related]
7. The frequency of the C9orf72 expansion in a Brazilian population.
Cintra VP; Bonadia LC; Andrade HMT; de Albuquerque M; Eusébio MF; de Oliveira DS; Claudino R; Gonçalves MVM; Teixeira AL; de Godoy Rousseff Prado L; de Souza LC; Dourado MET; Oliveira ASB; Tumas V; França MC; Marques W
Neurobiol Aging; 2018 Jun; 66():179.e1-179.e4. PubMed ID: 29449030
[TBL] [Abstract][Full Text] [Related]
8. C9orf72 hexanucleotide repeat expansions and Ataxin 2 intermediate length repeat expansions in Indian patients with amyotrophic lateral sclerosis.
Narain P; Gomes J; Bhatia R; Singh I; Vivekanandan P
Neurobiol Aging; 2017 Aug; 56():211.e9-211.e14. PubMed ID: 28527524
[TBL] [Abstract][Full Text] [Related]
9. Network degeneration and dysfunction in presymptomatic
Lee SE; Sias AC; Mandelli ML; Brown JA; Brown AB; Khazenzon AM; Vidovszky AA; Zanto TP; Karydas AM; Pribadi M; Dokuru D; Coppola G; Geschwind DH; Rademakers R; Gorno-Tempini ML; Rosen HJ; Miller BL; Seeley WW
Neuroimage Clin; 2017; 14():286-297. PubMed ID: 28337409
[TBL] [Abstract][Full Text] [Related]
10. Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72.
Davidson YS; Barker H; Robinson AC; Thompson JC; Harris J; Troakes C; Smith B; Al-Saraj S; Shaw C; Rollinson S; Masuda-Suzukake M; Hasegawa M; Pickering-Brown S; Snowden JS; Mann DM
Acta Neuropathol Commun; 2014 Jun; 2():70. PubMed ID: 24950788
[TBL] [Abstract][Full Text] [Related]
11. The most prevalent genetic cause of ALS-FTD, C9orf72 synergizes the toxicity of ATXN2 intermediate polyglutamine repeats through the autophagy pathway.
Ciura S; Sellier C; Campanari ML; Charlet-Berguerand N; Kabashi E
Autophagy; 2016 Aug; 12(8):1406-8. PubMed ID: 27245636
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers.
Mackenzie IR; Frick P; Grässer FA; Gendron TF; Petrucelli L; Cashman NR; Edbauer D; Kremmer E; Prudlo J; Troost D; Neumann M
Acta Neuropathol; 2015 Dec; 130(6):845-61. PubMed ID: 26374446
[TBL] [Abstract][Full Text] [Related]
13. Novel clinical associations with specific C9ORF72 transcripts in patients with repeat expansions in C9ORF72.
van Blitterswijk M; Gendron TF; Baker MC; DeJesus-Hernandez M; Finch NA; Brown PH; Daughrity LM; Murray ME; Heckman MG; Jiang J; Lagier-Tourenne C; Edbauer D; Cleveland DW; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Petrucelli L; Boeve BF; Graff-Radford NR; Boylan KB; Dickson DW; Rademakers R
Acta Neuropathol; 2015 Dec; 130(6):863-76. PubMed ID: 26437865
[TBL] [Abstract][Full Text] [Related]
14. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72.
Murray ME; DeJesus-Hernandez M; Rutherford NJ; Baker M; Duara R; Graff-Radford NR; Wszolek ZK; Ferman TJ; Josephs KA; Boylan KB; Rademakers R; Dickson DW
Acta Neuropathol; 2011 Dec; 122(6):673-90. PubMed ID: 22083254
[TBL] [Abstract][Full Text] [Related]
15. OPTN p.Met468Arg and ATXN2 intermediate length polyQ extension in families with C9orf72 mediated amyotrophic lateral sclerosis and frontotemporal dementia.
Farhan SMK; Gendron TF; Petrucelli L; Hegele RA; Strong MJ
Am J Med Genet B Neuropsychiatr Genet; 2018 Jan; 177(1):75-85. PubMed ID: 29080331
[TBL] [Abstract][Full Text] [Related]
16. ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion.
Chiò A; Mora G; Sabatelli M; Caponnetto C; Lunetta C; Traynor BJ; Johnson JO; Nalls MA; Calvo A; Moglia C; Borghero G; Trojsi F; La Bella V; Volanti P; Simone I; Salvi F; Logullo FO; Riva N; Carrera P; Giannini F; Mandrioli J; Tanel R; Capasso M; Tremolizzo L; Battistini S; Murru MR; Origone P; Zollino M; Penco S; ; ; Mazzini L; D'Alfonso S; Restagno G; Brunetti M; Barberis M; Conforti FL
Neurobiol Aging; 2016 Mar; 39():218.e5-8. PubMed ID: 26733254
[TBL] [Abstract][Full Text] [Related]
17. C9orf72 and ATXN2 repeat expansions coexist in a family with ataxia, dementia, and parkinsonism.
Zhang M; Xi Z; Misquitta K; Sato C; Moreno D; Liang Y; Slow E; Rogaeva E; Tartaglia MC
Mov Disord; 2017 Jan; 32(1):158-162. PubMed ID: 28124431
[TBL] [Abstract][Full Text] [Related]
18. Hippocampal sclerosis dementia with the C9ORF72 hexanucleotide repeat expansion.
Pletnikova O; Sloane KL; Renton AE; Traynor BJ; Crain BJ; Reid T; Zu T; Ranum LP; Troncoso JC; Rabins PV; Onyike CU
Neurobiol Aging; 2014 Oct; 35(10):2419.e17-21. PubMed ID: 24819148
[TBL] [Abstract][Full Text] [Related]
19. Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers.
Jackson JL; Finch NA; Baker MC; Kachergus JM; DeJesus-Hernandez M; Pereira K; Christopher E; Prudencio M; Heckman MG; Thompson EA; Dickson DW; Shah J; Oskarsson B; Petrucelli L; Rademakers R; van Blitterswijk M
Mol Neurodegener; 2020 Jan; 15(1):7. PubMed ID: 32000838
[TBL] [Abstract][Full Text] [Related]
20. Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features.
Sha SJ; Takada LT; Rankin KP; Yokoyama JS; Rutherford NJ; Fong JC; Khan B; Karydas A; Baker MC; DeJesus-Hernandez M; Pribadi M; Coppola G; Geschwind DH; Rademakers R; Lee SE; Seeley W; Miller BL; Boxer AL
Neurology; 2012 Sep; 79(10):1002-11. PubMed ID: 22875087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
